Yasutaka Okita

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 6

Top Topics

Rheumatoid Arthritis

Ankylosing Spondylitis

Cerebral Blood Flow

Top Venues

The Journal of rheumatology

Nature communications

Clinical rheumatology

This page only lists publications with an associated author ORCID identifier.

Publications

Yasutaka Okita, Masashi Okamoto, Jun Fujimoto, Atsushi Kumanogoh
Pneumocephalus and Cerebral Abscess in Granulomatosis With Polyangiitis. The Journal of rheumatology 51 (8) (2024)
Yasutaka Okita, Masashi Okamoto, Jun Fujimoto, Atsushi Kumanogoh
Pneumocephalus and Cerebral Abscess in Granulomatosis With Polyangiitis. The Journal of rheumatology (2024)
Kosuke Ebina, Yuki Etani, Yuichi Maeda, Yasutaka Okita, Makoto Hirao, Wataru Yamamoto, Motomu Hashimoto, Koichi Murata, Ryota Hara, Koji Nagai, Yuri Hiramatsu, Yonsu Son, Hideki Amuro, Takayuki Fujii, Takaichi Okano, Yo Ueda, Masaki Katayama, Tadashi Okano, Shotaro Tachibana, Tomoyuki Kamenaga, Atsushi Kumanogoh, Seiji Okada, Ken Nakata
Drug retention of biologics and Janus kinase inhibitors in patients with rheumatoid arthritis: the ANSWER cohort study. RMD open 9 (3) (2023)
Yasutaka Okita, Toru Hirano, Bowen Wang, Yuta Nakashima, Saki Minoda, Hajime Nagahara, Atsushi Kumanogoh
Automatic evaluation of atlantoaxial subluxation in rheumatoid arthritis by a deep learning model. Arthritis research & therapy 25 (1) (2023)
Tsunaki Higa, Yasutaka Okita, Akinobu Matsumoto, Shogo Nakayama, Takeru Oka, Osamu Sugahara, Daisuke Koga, Shoichiro Takeishi, Hirokazu Nakatsumi, Naoki Hosen, Sylvie Robine, Makoto M Taketo, Toshiro Sato, Keiichi I Nakayama
Spatiotemporal reprogramming of differentiated cells underlies regeneration and neoplasia in the intestinal epithelium. Nature communications 13 (1) (2022)
Kosuke Ebina, Toru Hirano, Yuichi Maeda, Wataru Yamamoto, Motomu Hashimoto, Koichi Murata, Akira Onishi, Sadao Jinno, Ryota Hara, Yonsu Son, Hideki Amuro, Tohru Takeuchi, Ayaka Yoshikawa, Masaki Katayama, Keiichi Yamamoto, Makoto Hirao, Yasutaka Okita, Atsushi Kumanogoh, Ken Nakata
Drug retention of sarilumab, baricitinib, and tofacitinib in patients with rheumatoid arthritis: the ANSWER cohort study. Clinical rheumatology 40 (7) (2021)